@article{deokar_agarwal_dutt_chauhan_niwas_shadrach_chawla_2021, 
  title={A review of Ciclesonide in COVID-19. Still a long way to go}, 
  DOI={10.5603/arm.a2020.0173}, 
  abstractNote={As no definitive therapy or vaccine is yet available for COVID-19, in a desperate attempt repurposed drugs are being explored as an option. A drug repurposing study identified Ciclesonide as a potential candidate. We reviewed the available evidence and clinical trials on the use of Ciclesonide in COVID-19. At present the evidence is limited to a report of three cases. However, five clinical trials are underway, and their results will help in elucidating the role of Ciclesonide in COVID-19.}, 
  author={Deokar, Kunal and Agarwal, Mehul and Dutt, Naveen and Chauhan, Nishant and Niwas, Ram and Shadrach, Benhur Joel and Chawla, Gopal}, 
  year={2021}, 
  month={Jan}
  }